|
Status |
Public on Dec 23, 2019 |
Title |
Gene Expressions responsible for good response to Nivolumab treatment |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Analysis of gene expression in CD62Lhigh CD4+ T cells and CD62Llow CD4+ T cells from good responder (GR), intermediate responder (IR), and non-responder (NR).
|
|
|
Overall design |
PBMC were obtained from two of each responder group; good responders, intermediate responders, and non-responders. CD4+ T cells were purified by negative selection using human CD4+ T cell isolation kits. CD4+ T cells were further separated into CD62Lhigh cells and CD62Llow cells by anti-CD62L mAb-coated microbeads and MACSTM system. We have invetigated the differences of gene expresion between CD62L high and low CD4+ Tcell from three kinds of patients groups.
|
|
|
Contributor(s) |
Kagamu H, Horimoto K, Kitazawa M |
Citation(s) |
31871122 |
Submission date |
Aug 28, 2017 |
Last update date |
Jul 25, 2021 |
Contact name |
Masashi Kitazawa |
E-mail(s) |
masashi-kitazawa@aist.go.jp
|
Organization name |
National of Institute of Advanced Industrial Science and Technology (AIST)
|
Street address |
2-4-7 Aomi
|
City |
Koto-ku, |
State/province |
Tokyo |
ZIP/Postal code |
135-0064 |
Country |
Japan |
|
|
Platforms (1) |
GPL23159 |
[Clariom_S_Human] Affymetrix Clariom S Assay, Human (Includes Pico Assay) |
|
Samples (12)
|
GSM2756250 |
CD62L high CD4+ T cells from good responder of patient 1; ICI-39 |
GSM2756251 |
CD62L high CD4+ T cells from good responder of patient 2; ICI-44 |
GSM2756252 |
CD62L high CD4+ T cells from intermediate responder of patient 1; ICI-17 |
GSM2756253 |
CD62L high CD4+ T cells from intermediate responder of patient 2; ICI-56 |
GSM2756254 |
CD62L high CD4+ T cells from non-responder of patient 1; ICI-21 |
GSM2756255 |
CD62L high CD4+ T cells from non-responder of patient 2; ICI-52 |
GSM2756256 |
CD62L low CD4+ T cells from good responder of patient 1; ICI-39 |
GSM2756257 |
CD62L low CD4+ T cells from good responder of patient 2; ICI-44 |
GSM2756258 |
CD62L low CD4+ T cells from intermediate responder of patient 1; ICI-17 |
GSM2756259 |
CD62L low CD4+ T cells from intermediate responder of patient 2; ICI-56 |
GSM2756260 |
CD62L low CD4+ T cells from non-responder of patient 1; ICI-21 |
GSM2756261 |
CD62L low CD4+ T cells from non-responder of patient 2; ICI-52 |
|
Relations |
BioProject |
PRJNA400373 |